Free Trial

Veradigm (MDRX) Competitors

Veradigm logo
$4.40 0.00 (0.00%)
As of 03:46 PM Eastern

MDRX vs. OMCL, HSTM, CRTX, NTCT, VRNT, RBBN, SLP, OSPN, ECX, and UIS

Should you be buying Veradigm stock or one of its competitors? The main competitors of Veradigm include Omnicell (OMCL), HealthStream (HSTM), Cortexyme (CRTX), NetScout Systems (NTCT), Verint Systems (VRNT), Ribbon Communications (RBBN), Simulations Plus (SLP), OneSpan (OSPN), ECARX (ECX), and Unisys (UIS).

Veradigm vs.

Veradigm (NASDAQ:MDRX) and Omnicell (NASDAQ:OMCL) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations.

In the previous week, Omnicell had 15 more articles in the media than Veradigm. MarketBeat recorded 17 mentions for Omnicell and 2 mentions for Veradigm. Omnicell's average media sentiment score of 0.94 beat Veradigm's score of 0.00 indicating that Omnicell is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veradigm
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Omnicell
6 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Omnicell has lower revenue, but higher earnings than Veradigm.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veradigm$1.53B0.31N/AN/AN/A
Omnicell$1.14B1.16$12.53M$0.4661.37

Veradigm presently has a consensus target price of $14.00, suggesting a potential upside of 218.18%. Omnicell has a consensus target price of $44.83, suggesting a potential upside of 58.81%. Given Veradigm's higher probable upside, equities research analysts plainly believe Veradigm is more favorable than Omnicell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veradigm
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Omnicell
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Omnicell has a net margin of 1.13% compared to Veradigm's net margin of 0.00%. Omnicell's return on equity of 3.82% beat Veradigm's return on equity.

Company Net Margins Return on Equity Return on Assets
VeradigmN/A N/A N/A
Omnicell 1.13%3.82%2.07%

97.7% of Omnicell shares are held by institutional investors. 2.3% of Veradigm shares are held by insiders. Comparatively, 2.5% of Omnicell shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Veradigm has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.

Veradigm received 122 more outperform votes than Omnicell when rated by MarketBeat users. However, 66.71% of users gave Omnicell an outperform vote while only 57.55% of users gave Veradigm an outperform vote.

CompanyUnderperformOutperform
VeradigmOutperform Votes
629
57.55%
Underperform Votes
464
42.45%
OmnicellOutperform Votes
507
66.71%
Underperform Votes
253
33.29%

Summary

Omnicell beats Veradigm on 11 of the 14 factors compared between the two stocks.

Get Veradigm News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDRX vs. The Competition

MetricVeradigmComputer integrated systems design IndustryBusiness SectorNASDAQ Exchange
Market Cap$476.37M$3.76B$24.21B$8.31B
Dividend YieldN/A2.13%2.62%4.10%
P/E RatioN/A65.1832.5319.60
Price / Sales0.3134.34252.54117.96
Price / CashN/A34.8530.9334.62
Price / BookN/A5.355.384.50
Net IncomeN/A$37.12M$195.96M$248.40M
7 Day Performance4.76%-1.29%-1.14%-1.00%
1 Month Performance6.02%13.86%15.11%10.72%
1 Year Performance-43.37%3.98%18.86%9.00%

Veradigm Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDRX
Veradigm
2.2644 of 5 stars
$4.40
flat
$14.00
+218.2%
-42.1%$476.37M$1.53B0.008,000Analyst Forecast
Gap Down
OMCL
Omnicell
2.4278 of 5 stars
$27.85
-0.4%
$46.50
+67.0%
-10.5%$1.30B$1.14B103.153,800Trending News
Analyst Upgrade
HSTM
HealthStream
4.5211 of 5 stars
$29.13
+2.2%
$31.50
+8.1%
+2.0%$889.19M$292.37M44.821,140
CRTX
Cortexyme
N/A$0.85
+1.3%
N/A+15.7%$25.63MN/A-0.2955
NTCT
NetScout Systems
1.2673 of 5 stars
$23.56
+1.1%
$25.00
+6.1%
+8.6%$1.69B$822.68M-4.022,330Positive News
VRNT
Verint Systems
4.547 of 5 stars
$17.93
-1.4%
$30.33
+69.2%
-44.9%$1.08B$909.19M19.074,400Positive News
Gap Down
RBBN
Ribbon Communications
4.695 of 5 stars
$3.64
+0.3%
$5.88
+61.4%
+11.7%$642.62M$835.50M-11.383,107Positive News
Gap Down
SLP
Simulations Plus
3.7007 of 5 stars
$31.33
-0.6%
$50.00
+59.6%
-35.0%$630.08M$78.56M78.33160Positive News
OSPN
OneSpan
4.5082 of 5 stars
$16.30
+0.4%
$19.50
+19.6%
+24.8%$623.15M$241.70M22.03790Positive News
Dividend Announcement
Analyst Downgrade
ECX
ECARX
1.9064 of 5 stars
$1.50
-5.7%
$3.20
+113.3%
+38.3%$556.10M$5.85B-3.002,000
UIS
Unisys
4.5203 of 5 stars
$5.24
-2.4%
$6.50
+24.0%
+3.6%$372.39M$1.95B-1.8516,200Positive News

Related Companies and Tools


This page (NASDAQ:MDRX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners